Literature DB >> 30416800

Sputum purulence-associated microbial community compositions in adults with bronchiectasis.

Wei-Jie Guan1,2, Yan Huang1, Chun-Lan Chen1, Jing-Jing Yuan1, Hui-Min Li1, Yong-Hua Gao3, Rong-Chang Chen1, Nan-Shan Zhong1,2.   

Abstract

Year:  2018        PMID： 30416800      PMCID： PMC6196201          DOI： 10.21037/jtd.2018.08.30

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  12 in total

Review 1.  British Thoracic Society guideline for non-CF bronchiectasis.

Authors:  M C Pasteur; D Bilton; A T Hill
Journal:  Thorax       Date:  2010-07       Impact factor: 9.139

2.  Inhaled fluticasone in bronchiectasis: a 12 month study.

Authors:  K W Tsang; K C Tan; P L Ho; G C Ooi; J C Ho; J Mak; G L Tipoe; C Ko; C Yan; W K Lam; M Chan-Yeung
Journal:  Thorax       Date:  2005-03       Impact factor: 9.139

3.  Sputum colour and bacteria in chronic bronchitis exacerbations: a pooled analysis.

Authors:  Marc Miravitlles; Frank Kruesmann; Daniel Haverstock; Renee Perroncel; Shurjeel H Choudhri; Pierre Arvis
Journal:  Eur Respir J       Date:  2011-10-27       Impact factor: 16.671

4.  Elastolytic activity of sputum and its relation to purulence and to lung function in patients with bronchiectasis.

Authors:  R A Stockley; S L Hill; H M Morrison; C M Starkie
Journal:  Thorax       Date:  1984-06       Impact factor: 9.139

5.  Sputum bacteriology in steady-state bronchiectasis in Guangzhou, China.

Authors:  W-J Guan; Y-H Gao; G Xu; Z-Y Lin; Y Tang; H-M Li; Z-M Lin; J-P Zheng; R-C Chen; N-S Zhong
Journal:  Int J Tuberc Lung Dis       Date:  2015-05       Impact factor: 2.373

6.  Sputum purulence-guided antibiotic use in hospitalised patients with exacerbations of COPD.

Authors:  Néstor Soler; Mariano Esperatti; Santiago Ewig; Arturo Huerta; Carlos Agustí; Antoni Torres
Journal:  Eur Respir J       Date:  2012-04-20       Impact factor: 16.671

7.  The Sputum Colour Chart as a predictor of lung inflammation, proteolysis and damage in non-cystic fibrosis bronchiectasis: a case-control analysis.

Authors:  Pieter C Goeminne; Jennifer Vandooren; Eva A Moelants; Ann Decraene; Evelyn Rabaey; Ans Pauwels; Sven Seys; Ghislain Opdenakker; Paul Proost; Lieven J Dupont
Journal:  Respirology       Date:  2013-11-29       Impact factor: 6.424

8.  Predominant pathogen competition and core microbiota divergence in chronic airway infection.

Authors:  Geraint B Rogers; Christopher J van der Gast; David J Serisier
Journal:  ISME J       Date:  2014-07-18       Impact factor: 10.302

9.  European Respiratory Society guidelines for the management of adult bronchiectasis.

Authors:  Eva Polverino; Pieter C Goeminne; Melissa J McDonnell; Stefano Aliberti; Sara E Marshall; Michael R Loebinger; Marlene Murris; Rafael Cantón; Antoni Torres; Katerina Dimakou; Anthony De Soyza; Adam T Hill; Charles S Haworth; Montserrat Vendrell; Felix C Ringshausen; Dragan Subotic; Robert Wilson; Jordi Vilaró; Bjorn Stallberg; Tobias Welte; Gernot Rohde; Francesco Blasi; Stuart Elborn; Marta Almagro; Alan Timothy; Thomas Ruddy; Thomy Tonia; David Rigau; James D Chalmers
Journal:  Eur Respir J       Date:  2017-09-09       Impact factor: 16.671

10.  Polymicrobial airway bacterial communities in adult bronchiectasis patients.

Authors:  Paul Purcell; Hannah Jary; Audrey Perry; John D Perry; Christopher J Stewart; Andrew Nelson; Clare Lanyon; Darren L Smith; Stephen P Cummings; Anthony De Soyza
Journal:  BMC Microbiol       Date:  2014-05-20       Impact factor: 3.605
View more
  1 in total

1.  Risk factors for bronchiectasis in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.

Authors:  XinXin Zhang; LiJian Pang; XiaoDong Lv; HaoYang Zhang
Journal:  Clinics (Sao Paulo)       Date:  2021-04-16       Impact factor: 2.365
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.